Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria

Bernardo Cavallazzi Sebold1,2, Junjie Li3, Guoying Ni1,3,4

  • 1Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore BC, QLD, 4558, Australia.

Insights

Multidrug-resistant bacteria pose a global threat. Chemical engineering of host defence peptides (HDPs) shows promise in improving their effectiveness against challenging pathogens like the ESKAPE group.

Area of Science:

  • Microbiology
  • Biochemistry
  • Medicinal Chemistry

Background:

  • Multidrug-resistant (MDR) bacteria, particularly the ESKAPE pathogens, represent a significant and growing global health concern.
  • Host defence peptides (HDPs) exhibit antimicrobial activity against MDR bacteria, including within biofilms.
  • The clinical application of HDPs is limited by poor pharmacokinetics in physiological environments.

Purpose of the Study:

  • To review chemical modifications of HDPs aimed at enhancing their pharmacokinetic properties and antimicrobial efficacy.
  • To highlight promising modifications effective against ESKAPE pathogens.

Main Methods:

  • Literature review of studies involving chemically modified HDPs.
  • Analysis of modifications targeting improved pharmacokinetics and antimicrobial activity.
  • Focus on efficacy against Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE pathogens).

Main Results:

  • Various chemical modifications have successfully improved HDP pharmacokinetics.
  • Modified HDPs demonstrate enhanced efficacy against ESKAPE pathogens in vitro and in vivo.
  • Specific modifications offer strategies to overcome limitations of native HDPs.

Conclusions:

  • Chemical engineering is a viable strategy to develop HDPs into effective clinical agents against MDR infections.
  • Modified HDPs hold significant potential for combating the threat posed by ESKAPE pathogens.
  • Further research into HDP modification is crucial for advancing antimicrobial therapies.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
48
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1.1K
Antibiotic Selection00:57

Antibiotic Selection

Overview
54.8K
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
49
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.1K